AUD 0.73
(-1.35%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -9.51 Million | -9.69 Million | -3.8 Million | -9.5 Million | -7.54 Million |
Net Income | -9.72 Million | -18.09 Million | -11.24 Million | -7.65 Million | -1.27 Million |
Depreciation & Amortization | 194.55 Thousand | 2.53 Million | 4.14 Million | 159.94 Thousand | 66.65 Thousand |
Deferred income taxes | - | -902.52 Thousand | -19.08 Million | - | - |
Stock-based compensation | 3.31 Million | 1.08 Million | 315 Thousand | - | - |
Change in working capital | -3.5 Million | -181.56 Thousand | 18.78 Million | -3.55 Million | -14.91 Million |
Other non-cash items | 215.44 Thousand | 5.85 Million | -15.8 Million | 1.55 Million | 8.58 Million |
Investing Cash Flow | -4.71 Million | -425.25 Thousand | -1.05 Million | -212.03 Thousand | -14.81 Thousand |
Investments in PPE | -4.71 Million | -425.25 Thousand | -1.05 Million | -212.03 Thousand | -2.42 Million |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -4.7 Million | - | - | - | 2.41 Million |
Financing Cash Flow | -214.63 Thousand | 27.63 Million | 4.91 Million | -82.02 Thousand | 18.37 Million |
Debt repayment | -183.66 Thousand | -119.59 Thousand | -65.27 Thousand | -54.78 Thousand | -20.9 Thousand |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -2.1 Million |
Common Stock Issuance | - | 28.66 Million | - | - | - |
Other Financing Activities | -183.66 Thousand | -912.15 Thousand | 4.97 Million | -27.23 Thousand | 20.5 Million |
Accounts receivables | -3.33 Million | -181.56 Thousand | 18.77 Million | -3.59 Million | -14.87 Million |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | -171.46 Thousand | -115.54 Thousand | 8455.00 | 40.41 Thousand | -40.83 Thousand |
Cash at beginning of period | 18.96 Million | 1.44 Million | 1.4 Million | 11.21 Million | 425.68 Thousand |
Cash at end of period | 4.51 Million | 18.96 Million | 1.44 Million | 1.4 Million | 11.21 Million |
Capital Expenditure | -4.71 Million | -425.25 Thousand | -1.05 Million | -212.03 Thousand | -2.42 Million |
Effect of forex changes on cash | -11.5 Thousand | 8696.00 | -11.75 Thousand | -13.04 Thousand | -29.6 Thousand |
Net cash flow / Change in cash | -14.44 Million | 17.51 Million | 38.06 Thousand | -9.81 Million | 10.78 Million |
Free Cash Flow | -14.22 Million | -10.12 Million | -4.86 Million | -9.71 Million | -9.97 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1748.28 | -1748.28 | -9.72 Million | -1319.77 | -1.31 Million | -3.54 Million |
Depreciation & Amortization | 49.75 | 49.75 | 194.55 Thousand | 46.78 | 46.77 Thousand | 50.49 Thousand |
Deferred income taxes | - | - | - | - | - | 986.38 Thousand |
Stock-based compensation | 154.40 | 154.40 | 3.31 Million | 901.73 | 901.73 Thousand | 753.37 Thousand |
Change in working capital | -187.14 | -187.14 | -3.5 Million | -0.66 | -659.00 | -1.75 Million |
Other non-cash items | -367.14 | -367.14 | 215.44 Thousand | -1293.84 | -1.29 Million | 1.4 Million |
Investing Cash Flow | -503.47 | -503.47 | -4.71 Million | -1408.26 | -1.4 Million | -948.37 Thousand |
Investments in PPE | -503.47 | -503.47 | -4.71 Million | -1408.26 | -1.4 Million | -948.37 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 4780.53 | 4780.53 | -214.63 Thousand | -53.31 | -53.31 Thousand | -54 Thousand |
Debt repayment | - | - | -183.66 Thousand | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 4780.53 | 4780.53 | -183.66 Thousand | -53.31 | -53.31 Thousand | -54 Thousand |
Accounts receivables | -233.97 | -233.97 | -3.33 Million | 74.52 | 74.52 Thousand | -1.73 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 46.84 | 46.84 | -171.46 Thousand | -75.18 | -75.18 Thousand | -10.54 Thousand |
Cash at beginning of period | - | - | 18.96 Million | -3.12 Million | - | - |
Cash at end of period | 2176.62 | 2176.62 | 4.51 Million | -3.13 Million | -3.13 Million | -4.09 Million |
Capital Expenditure | -503.47 | -503.47 | -4.71 Million | -1408.26 | -1.4 Million | -948.37 Thousand |
Effect of forex changes on cash | -2.04 | -2.04 | -11.5 Thousand | -3.29 | -3294.00 | -2456.00 |
Net cash flow / Change in cash | 2176.62 | 2176.62 | -14.44 Million | -3130.62 | -3.13 Million | -4.09 Million |
Free Cash Flow | -2601.87 | -2601.87 | -14.22 Million | -3074.02 | -3.07 Million | -4.03 Million |
SRV1V
CARE
CDI
SWZCF
BSPA
372170